University Spinout Fundraising in the UK (2026)
How the university's stake, the IP deal and pre-seed programmes shape a spinout's first round, with the 2023 review terms and current data.
What a spinout is, and the market today
A spinout is a company formed to commercialise research from a university, usually with the university holding shares in return for intellectual property. Raising for one follows the same steps as any startup round, with one extra party at the table.
The British Business Bank's 2026 equity tracker gives the current picture. UK spinout venture capital activity in 2021 to 2025 ranked second only to the US, with deal counts up 95% on 2016 to 2020 and investment rising from £2.7 billion to £7.5 billion. Momentum reversed in 2025, when equity deals involving spinouts fell by 33% and investment by 51% compared with 2024.
Geography shows up in the data too. The tracker reports that 49% of spinouts in the Golden Triangle raise equity, compared with 38% in the Northern Growth Corridor, and that one in five spinout deals received support from the Bank. This is general information, not financial or legal advice.
The university's equity stake
The terms of the university deal affect every later round, so settle them with care. The Independent Review of University Spin-out Companies, led by Professor Irene Tracey and Dr Andrew Williamson and published on 21 November 2023, gave reference points.
The review said the equity splits in TenU's University Spin-out Investment Terms guide can be used as a starting point for life sciences spinouts, at 10% to 25% university equity. For less IP-intensive sectors such as software, it pointed to 10% or less. The government accepted all of the review's recommendations.
I'd take those ranges into the first conversation with the technology transfer office. Ask what the university's standard position is and how it compares. A large university stake leaves less room for founders, new investors and an option pool, and seed investors will look at what the founders own after the round.
The IP licence or assignment
Investors fund a spinout because it has the right to use the research. Check exactly what the company receives: an assignment of the intellectual property or a licence, whether a licence is exclusive, in which fields and territories, and what royalties or milestone payments are due.
The TenU guide was written by university technology transfer offices with venture investors and covers equity share and IP, with the aim of more standard deal structures. The review also called for a template for spinout term sheets and for deals to be agreed on market terms without unnecessary negotiation.
Ask for the term sheet early and have a lawyer who has done spinout deals read it. Terms I'd question include broad rights for the university to take the IP back, royalties with no end date and consent rights over future funding.
Agree a timetable with the technology transfer office
The review recommended clearly stated expectations on the time taken to complete each stage of the spinout process. Use that. Ask the office for its timetable in writing, with named contacts and decision dates.
It also recommended a national register of spinouts and that universities publish more information about their typical deal terms. Look for your university's published terms before you negotiate, and ask founders of its recent spinouts how their deals went.
Run the university process and the investor process side by side. An investor's term sheet gives the transfer office a reason to conclude, and a signed IP agreement gives the investor confidence to close.
Funding before the first equity round
Public programmes pay for the stage between a research result and an investable company. UK Research and Innovation runs a proof of concept programme each year for early commercialisation of new products, services or processes, and several research councils run their own, including the Medical Research Council and the Science and Technology Facilities Council.
Innovate UK's ICURe programme helps researchers test whether an idea could become a spinout or a licensing opportunity. It runs in stages: a four-week part-time Engage stage, a ten-week part-time Discover stage, a twelve-week full-time Explore stage with up to £35,000 for the entrepreneurial lead's salary and costs, and a twelve-week Exploit stage for teams recommended for spin-out.
In its response to the review, the government committed to a new £20 million cross-disciplinary proof-of-concept fund. I'd use these programmes to gather market evidence. In my view customer conversations carry more weight with seed investors than another round of lab results.
SEIS, EIS and knowledge-intensive status
A spinout can use SEIS and EIS like any other qualifying company, and a research-led one may qualify as a knowledge-intensive company. From 6 April 2026 a knowledge-intensive company can raise up to £20 million a year and £40 million over its lifetime under the venture capital schemes.
Section 252A of the Income Tax Act 2007 sets the tests. At least 15% of operating costs must have gone on research and development or innovation in one of the three preceding years, or at least 10% in each. The company must also meet an innovation condition based on creating intellectual property, or have skilled employees making up at least 20% of full-time equivalent staff. Ask your adviser how the tests apply to a newly formed company.
Check how the university's shareholding and any licence payments sit with the scheme rules, and apply for advance assurance before you approach angels. HMRC asks for your articles and details of any other agreements between the company and its shareholders, which for a spinout includes the university documents.
The team investors want to see
Academic founders often stay in their university posts. Investors accept that, and they will ask who works on the company full time. Be clear about each founder's role, time commitment and shareholding.
If nobody on the founding team has commercial experience, say how you will fill the gap: a full-time chief executive, an experienced chair or an adviser with a record in your market.
Match shareholdings to commitment. A founder who stays full time in academia and one who leaves to run the company are taking different risks, and the cap table should show that. Vesting for all founders reassures investors.
Finding the right investors
Spinouts raise from a recognisable group: funds linked to universities, deep technology seed funds, angels with a scientific background and public-backed programmes. The review's later recommendations dealt with university-affiliated funds and access to scale-up capital.
Start with investors who have backed a spinout in your field in the last two years. They already know how to work with a transfer office and will be patient with the process.
Then pitch the business as well as the science. Lead with the customer, the problem and the evidence that someone will pay, and keep the technical depth for the second meeting.
See which UK investors fit you
Give us your website and raise. We rank UK investors against your company and explain each fit. Your top 10 are free.
Find my investorsSources
- British Business Bank: Small Business Equity Tracker 2026
- GOV.UK: Independent review of university spin-out companies
- GOV.UK: Independent review of university spin-out companies, government response
- University of Oxford: Government welcomes university spin-out review
- TenU: The USIT Guide
- UKRI: Prove your concept
- Innovate UK Business Connect: ICURe
- GOV.UK: EIS and VCT changes, investment limit increase and restructure
- Income Tax Act 2007, section 252A
- HMRC: Apply for advance assurance